Showing results (141-150 of 250) with videos related to
Sort By:
Pageof 25
Analytical Chemistry|February 26, 2011
Kinetically-calibrated solid-phase microextraction using label-free standards and its application for pharmaceutical analysisXu Zhang, Ken D Oakes, Di Luong, et al.Journal of Vascular Surgery|March 7, 2019
Long-term durability of Oakes salvage procedure to preserve Brescia-Cimino arteriovenous fistulaAnahita Dua, Kara A Rothenberg, Kedar Lavingia, et al.British Journal of Industrial Medicine|January 1, 1988
Mortality of workers at acetylene production plantsM L Newhouse, G Matthews, K Sheikh, et al.The American Journal of Physiology|December 31, 1997
Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653C Schmitz-Peiffer, N D Oakes, C L Browne, et al.European Journal of Pharmacology|May 6, 2006
PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar ratsAmanda J Edgley, Pia G Thalén, Björn Dahllöf, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 27, 2005
Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker ratsNicholas D Oakes, Pia Thalén, Therese Hultstrand, et al.Journal of Hazardous Materials|March 8, 2011
Hydrothermal growth of free standing TiO2 nanowire membranes for photocatalytic degradation of pharmaceuticalsAnming Hu, Xu Zhang, Ken D Oakes, et al.Surgery|March 1, 1982
Transplantation in patients with a history of renal cell carcinoma: long-term results and clinical considerationsE K Spees, J A Light, E J Smith, et al.The Annals of Thoracic Surgery|November 1, 1982
Lateral thoracotomy and one-lung anesthesia in patients with morbid obesityD D Oakes, R B Cohn, J B Brodsky, et al.Endocrinology|April 3, 2004
Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazarBronwyn D Hegarty, Stuart M Furler, Nicholas D Oakes, et al.Pageof 25